Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis.

Autor: Savelkoul EHJ; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, the Netherlands., Thomas PWA; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, the Netherlands., Derikx LAAP; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, the Netherlands., den Broeder N; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, the Netherlands., Römkens TEH; Department of Gastroenterology and Hepatology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, the Netherlands., Hoentjen F; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, the Netherlands.; Division of Gastroenterology, University of Alberta, Edmonton, Canada.

Publikováno v: Inflammatory bowel diseases [Inflamm Bowel Dis] 2023 Oct 03; Vol. 29 (10), pp. 1633-1647.

Health State Questionnaires Deployed in Ulcerative Colitis Patients: The Medical, Psychological, and Economic Perspective.

Autor: Broekharst DSE; Center for Marketing & Supply Chain Management, Nyenrode Business University, Breukelen, the Netherlands., Thomas PWA; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands., Russel MGVM; Department of Gastroenterology and Hepatology, Medisch Spectrum Twente, Enschede, the Netherlands., West RL; Department of Gastroenterology and Hepatology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., Jansen JM; Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands., Bloem S; Center for Marketing & Supply Chain Management, Nyenrode Business University, Breukelen, the Netherlands., Römkens TEH; Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, Den Bosch, the Netherlands.

Publikováno v: Gastro hep advances [Gastro Hep Adv] 2023 Mar 18; Vol. 2 (6), pp. 770-777. Date of Electronic Publication: 2023 Mar 18 (Print Publication: 2023).

Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.

Autor: Thomas PWA; Department of Gastroenterology and Hepatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands., den Broeder N; Department of Gastroenterology and Hepatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands., Derikx M; Occupational Medicine, Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands., Kievit W; Radboud Institute for Health Sciences, Department for Health Evidence, Radboud University Medical Centre, The Netherlands., West RL; Department of Gastroenterology and Hepatology, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands., Russel MGVM; Department of Gastroenterology and Hepatology, Medical Spectrum Twente, Enschede, The Netherlands., Jansen JM; Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., Römkens TEH; Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Hoentjen F; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands and Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada.

Publikováno v: Inflammatory bowel diseases [Inflamm Bowel Dis] 2022 Dec 01; Vol. 28 (12), pp. 1813-1820.

Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy.

Autor: Thomas PWA; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands., Römkens TEH; Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., West RL; Department of Gastroenterology and Hepatology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Russel MGVM; Department of Gastroenterology and Hepatology, Medical Spectrum Twente, Enschede, The Netherlands., Jansen JM; Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., van Lint JA; Netherlands Pharmacovigilance Centre LAREB, 's-Hertogenbosch, The Netherlands., Jessurun NT; Netherlands Pharmacovigilance Centre LAREB, 's-Hertogenbosch, The Netherlands., Hoentjen F; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Publikováno v: United European gastroenterology journal [United European Gastroenterol J] 2021 Oct; Vol. 9 (8), pp. 919-928. Date of Electronic Publication: 2021 Jun 02.

Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring system.

Autor: Thomas PWA; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands., West RL; Department of Gastroenterology and Hepatology, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands., Russel MGVM; Department of Gastroenterology and Hepatology, Medisch Spectrum Twente, Enschede, The Netherlands., Jansen JM; Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., Kosse LJ; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., Jessurun NT; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., Römkens TEH; Department of Gastroenterology and Hepatology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands., Hoentjen F; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Publikováno v: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2021 Apr; Vol. 30 (4), pp. 520-524. Date of Electronic Publication: 2020 Dec 01.